PedAM
Pediatric Disease Annotations & Medicines
| Disease | iron deficiency anemia |
| Phenotype | C0022658|kidney disease |
| Sentences | 11 |
| PubMedID- 23701359 | Intravenous polynuclear iron formulations are vital components in the treatment of iron deficiency anemia associated with chronic kidney disease as well as other diseases associated with gastro-intestinal and cardio-vascular system. |
| PubMedID- 21479141 | The use of iron to address iron deficiency anemia associated with chronic kidney disease stages 1–4 has now extended to low clearance (predialysis, stage 5 nondialysis) patients and patients undergoing continuous ambulatory peritoneal dialysis. |
| PubMedID- 23766655 | Ferumoxytol is also being investigated in phase 3 studies for the treatment of iron deficiency anemia in patients without chronic kidney disease, including subgroups with ibd. |
| PubMedID- 23222534 | Intravenous ferric carboxymaltose versus standard medical care in the treatment of iron deficiency anemia in patients with chronic kidney disease: a randomized, active-controlled, multi-center study. |
| PubMedID- 21956770 | Ferumoxytol is a new product approved for intravenous use by the us food and drug administration (fda) in the treatment of iron deficiency anemia in adults with chronic kidney disease. |
| PubMedID- 26200671 | Pharmaceutical iron sucrose is an iron (iii) replacement for the treatment of iron deficiency anemia in patients with chronic kidney disease. |
| PubMedID- 21340038 | Ferumoxytol (amag pharmaceuticals inc, cambridge, ma) is approved for the sole indication of adult iron deficiency anemia associated with chronic kidney disease. |
| PubMedID- 25427433 | Background: ferumoxytol is an ultrasmall superparamagnetic iron oxide (uspio) nanoparticle agent used to treat iron deficiency anemia in adults with chronic kidney disease. |
| PubMedID- 22045905 | Ferumoxytol, a medication approved for treatment of iron deficiency anemia in adults with chronic kidney disease, has superparamagnetic properties. |
| PubMedID- 20030475 | Ferumoxytol: a new intravenous iron preparation for the treatment of iron deficiency anemia in patients with chronic kidney disease. |
| PubMedID- 25449870 | Ferumoxytol is an ultrasmall superparamagnetic iron oxide (uspio) nanoparticle that is fda-approved as an intravenous iron replacement therapy for the treatment of iron deficiency anemia in patients with chronic kidney disease. |
Page: 1